Seegene Unveils Blueprint for the Future of Molecular Diagnostics, Including Open Development Platform at the 40th Annual J.P. Morgan Healthcare Conference
Seegene Inc. (KQ 096530), South Korea’s leading
molecular diagnostics (MDx) company, today, unveiled its
blueprint for the future during a presentation at the 40th annual J.P. Morgan
Healthcare vir...
PR Newswire